Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design. [electronic resource]
Producer: 20180123Description: 9205-9221 p. digitalISSN:- 1520-4804
- Amino Acid Substitution
- Anaplastic Lymphoma Kinase
- Animals
- Antineoplastic Agents -- administration & dosage
- Carbazoles -- pharmacology
- Cell Line, Tumor
- Crizotinib
- Drug Design
- Drug Resistance, Neoplasm
- ERG1 Potassium Channel -- antagonists & inhibitors
- Humans
- Kinetics
- Piperidines -- pharmacology
- Pyrazoles -- pharmacology
- Pyridines -- pharmacology
- Pyrimidines -- pharmacology
- Quinolines -- administration & dosage
- Rats
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Signal Transduction
- Structure-Activity Relationship
- Sulfones -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.